Silence Therapeutics (SLN) News Today $5.91 +0.18 (+3.14%) Closing price 04:00 PM EasternExtended Trading$5.93 +0.02 (+0.34%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SLN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Analysts Set Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Target Price at $33.83July 5 at 2:33 AM | americanbankingnews.comSilence Therapeutics (NASDAQ:SLN) Rating Increased to Hold at Wall Street ZenJune 14, 2025 | marketbeat.comHC Wainwright Reiterates "Buy" Rating for Silence Therapeutics (NASDAQ:SLN)June 13, 2025 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Receives Buy Rating from Chardan CapitalJune 13, 2025 | marketbeat.comSilence Therapeutics Presents Additional Phase 1 Data Highlighting Promise of Divesiran as the Potential First-in-Class siRNA Treatment for Polycythemia VeraJune 12, 2025 | businesswire.comSilence Therapeutics plc (NASDAQ:SLN) Receives Average Rating of "Moderate Buy" from AnalystsJune 7, 2025 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Short Interest UpdateJune 4, 2025 | marketbeat.comMillennium Management LLC Reduces Stock Position in Silence Therapeutics plc (NASDAQ:SLN)June 1, 2025 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Shares Acquired by Bank of America Corp DEJune 1, 2025 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Shares Bought by Woodline Partners LPMay 27, 2025 | marketbeat.comPoint72 Asset Management L.P. Has $4.36 Million Stock Position in Silence Therapeutics plc (NASDAQ:SLN)May 22, 2025 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Receives Average Recommendation of "Moderate Buy" from AnalystsMay 15, 2025 | marketbeat.comIntegral Health Asset Management LLC Takes Position in Silence Therapeutics plc (NASDAQ:SLN)May 14, 2025 | marketbeat.comWhat is William Blair's Forecast for SLN FY2027 Earnings?May 14, 2025 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Price Target Lowered to $35.00 at Chardan CapitalMay 11, 2025 | marketbeat.comSilence Therapeutics (SLN) Projected to Post Quarterly Earnings on ThursdayMay 10, 2025 | marketbeat.comSilence Therapeutics plc GAAP EPS of -C$0.20May 8, 2025 | seekingalpha.comCantor Fitzgerald L. P. Buys 205,534 Shares of Silence Therapeutics plc (NASDAQ:SLN)May 7, 2025 | marketbeat.comSilence Therapeutics plc: Silence Therapeutics Welcomes Tim McInerney to Board of DirectorsMay 6, 2025 | finanznachrichten.deSilence Therapeutics Welcomes Tim McInerney to Board of DirectorsMay 6, 2025 | businesswire.comSilence Therapeutics plc (NASDAQ:SLN) Stock Holdings Increased by Nantahala Capital Management LLCApril 30, 2025 | marketbeat.comBoothbay Fund Management LLC Has $2.42 Million Position in Silence Therapeutics plc (NASDAQ:SLN)April 30, 2025 | marketbeat.comMarshall Wace LLP Purchases 320,472 Shares of Silence Therapeutics plc (NASDAQ:SLN)April 28, 2025 | marketbeat.comSilence Therapeutics plc (SLN): Among Takeover Rumors Hedge Funds Are BuyingApril 23, 2025 | insidermonkey.comSilence Therapeutics plc (NASDAQ:SLN) Given Average Rating of "Moderate Buy" by BrokeragesApril 20, 2025 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Earns "Buy" Rating from HC WainwrightMarch 8, 2025 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Given New $45.00 Price Target at Morgan StanleyMarch 6, 2025 | marketbeat.comBMO Capital Markets Cuts Silence Therapeutics (NASDAQ:SLN) Price Target to $25.00March 5, 2025 | marketbeat.comSilence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare ConferenceMarch 5, 2025 | businesswire.comSilence Therapeutics (SLN) Expected to Announce Quarterly Earnings on WednesdayMarch 5, 2025 | marketbeat.comThe Goldman Sachs Group Cuts Silence Therapeutics (NASDAQ:SLN) Price Target to $4.00March 4, 2025 | marketbeat.comSilence Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS LagsMarch 1, 2025 | uk.finance.yahoo.comSilence Therapeutics (NASDAQ:SLN) Announces Quarterly Earnings Results, Beats Estimates By $0.43 EPSFebruary 28, 2025 | marketbeat.comSilence Therapeutics plc (SLN) Q4 2024 Earnings Call TranscriptFebruary 28, 2025 | seekingalpha.comSilence Therapeutics Reports Full Year 2024 Financial Results and Provides Business UpdateFebruary 27, 2025 | businesswire.comSilence Therapeutics plc (NASDAQ:SLN) Given Average Recommendation of "Moderate Buy" by AnalystsFebruary 27, 2025 | marketbeat.comSilence Therapeutics (SLN) Expected to Announce Quarterly Earnings on ThursdayFebruary 21, 2025 | marketbeat.comShort Interest in Silence Therapeutics plc (NASDAQ:SLN) Rises By 15.0%February 16, 2025 | marketbeat.comGoldman Sachs Initiates Coverage of Silence Therapeutics plc - Depositary Receipt () (SLN) with Sell RecommendationFebruary 11, 2025 | msn.comSilence Therapeutics hit with new Sell at Goldman Sachs on resource constraintsFebruary 11, 2025 | seekingalpha.comSilence Therapeutics initiated with a Sell at Goldman SachsFebruary 11, 2025 | markets.businessinsider.comGoldman starts Silence Therapeutics at Sell on ‘undifferentiated’ dataFebruary 11, 2025 | markets.businessinsider.comGoldman Sachs cuts Silence Therapeutics stock rating to SellFebruary 11, 2025 | msn.comThe Goldman Sachs Group Begins Coverage on Silence Therapeutics (NASDAQ:SLN)February 11, 2025 | marketbeat.comHC Wainwright Has Negative Outlook of SLN FY2024 EarningsFebruary 3, 2025 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Receives Average Rating of "Buy" from BrokeragesFebruary 2, 2025 | marketbeat.comAnalysts Issue Forecasts for SLN FY2029 EarningsJanuary 31, 2025 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Given Buy Rating at HC WainwrightJanuary 29, 2025 | marketbeat.comSilence Therapeutics plc (NASDAQ:SLN) Receives Average Recommendation of "Buy" from AnalystsJanuary 8, 2025 | marketbeat.comSilence Therapeutics (NASDAQ:SLN) Shares Down 9.3% - Here's What HappenedJanuary 8, 2025 | marketbeat.com Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address SLN Media Mentions By Week SLN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼0.000.57▲Average Medical News Sentiment SLN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼12▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AIMDW News BCTXW News COCP News ENGNW News FBIOP News GLPG News GOVXW News LEXXW News MEIP News NTHI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLN) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Silence Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SLN Stock Alerts